EC Paediatrics

Glycated haemoglobin does not allow you to highlight the effects that food choices, physical activity and medications have on your glycaemic control day by day. The best way to monitor and keep track of the immediate effects that these have on your blood sugar levels is self-monitoring, therefore the use of a glucometer. Thanks to this tool you have the possibility to promptly receive information that helps you to intervene in the most appropriate way, bringing or keeping your blood sugar levels as close as possible to the reference values indicated by your doctor. Currently, blood glucose meters are used to measure and control blood glucose. Diabetes is a fairly complex disease and it is important for those who suffer from it to check their blood sugar (blood sugar) periodically throughout the day to prevent dangerous complications. Many children newly diagnosed with diabetes and their families may face unique challenges when dealing with the everyday management of diabetes, including treatments, adapting to dietary changes, and the routine monitoring of blood glucose. Many questions may also arise when selecting a blood glucose meter for paediatric patients. With current blood glucose meters, even with multiple daily self-tests, high and low blood glucose levels may not be detected. Key factors that may be considered when selecting a meter include accuracy of the meter; size of the meter; small sample size required for testing; ease of use and easy-to-follow testing procedure; ability for alternate testing sites; quick testing time and availability of results; ease of portability to allow testing at school and during leisure time; easy-to-read numbers on display; memory options; cost of meter and supplies. In this study we will show a new automatic portable, non-invasive device and painless for the daily continuous monitoring (24 hours a day) of blood glucose in paediatric patients.

 Keywords: Glucose; Glucometer; Diabetes; Blood Glucose Monitoring; Arduino; Non-Invasive Examination

1. M Sinisterra., et al. “Young children with type 1 diabetes: sleep, health-related quality of life, and continuous glucose monitor use”. Diabetes Technology and Therapeutics8 (2020): 639-642.
2. BH McAdams and AA Rizvi. “An overview of insulin pumps and glucose sensors for the generalist”. Interdisciplinary Materials1 (2016): 5.
3. G Li and D Wen. “Wearable biochemical sensors for human health monitoring: sensing materials and manufacturing technologies”. Journal of Materials Chemistry B 16 (2020): 3423-3436.
4. JE Shaw., et al. “Global estimates of the prevalence of diabetes for 2010 and 2030”. Diabetes Research and Clinical Practice 1 (2010): 4-14.
5. M Castellana., et al. “Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis”. BMJ Open Diabetes Research and Care 1 (2020): e001092.
6. l Lee., et al. “Continuous glucose monitoring systems - Current status and future perspectives of the flagship technologies in biosensor research”. Biosensors and Bioelectronics1 (2021): 113054.
7. M Baghelani., et al. “Non-invasive continuous-time glucose monitoring system using a chipless printable sensor based on split ring microwave resonators”. Nature Scientific Reports1 (2020): 12980.
8. X Jin., et al. “Artificial intelligence biosensors for continuous glucose monitoring”. Interdisciplinary Materials 2 (2023): 290-307.
9. F Urbano., et al. “Pediatric type 1 diabetes: mechanisms and impact of technologies on comorbidities and life expectancy”. International Journal of Molecular Sciences 15 (2023): 11980.
10. T Battelino and RM Bergenstal. “Continuous glucose monitoring-derived data report-simply a better management tool”. Diabetes Care10 (2020): 2327-2329.
11. T Battelino., et al. “Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range”. Diabetes Care8 (2019): 1593-1603.
12. O Onisie., et al. “The CGM grey market: a reflection of global access inequity”. Lancet Diabetes and Endocrinology 11 (2019): 823-825.
13. N Oliver., et al. “Continuous glucose monitoring in people with type 1 diabetes on multiple- dose injection therapy: the relationship between glycemic control and hypoglycemia”. Diabetes Care1 (2020): 53-58.
14. F Amaro., et al. “Continuous glucose monitoring (CGM) and metabolic control in a cohort of patients with type 1 diabetes and coeliac disease”. Endocrines3 (2023): 595-606.
15. E Teo., et al. “Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis”. Diabetologia4 (2022): 604-619.
16. MA Burckhardt., et al. “Use of remote monitoring with continuous glucose monitoring in young children with type 1 diabetes: the parents’ perspective”. Diabetic Medicine 11 (2019): 1453-1459.